9,285 Shares in The Clorox Company $CLX Purchased by Financial Solutions Advisory Group Inc.

Financial Solutions Advisory Group Inc. acquired a new position in shares of The Clorox Company (NYSE:CLX) during the first quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 9,285 shares of the company’s stock, valued at approximately $962,000.

Several other hedge funds have also recently bought and sold shares of CLX. Norges Bank acquired a new stake in shares of Clorox during the 4th quarter worth approximately $135,735,000. Invesco Ltd. increased its stake in Clorox by 22.1% in the fourth quarter. Invesco Ltd. now owns 4,880,341 shares of the company’s stock valued at $492,085,000 after acquiring an additional 884,751 shares during the last quarter. Northwestern Mutual Wealth Management Co. raised its position in Clorox by 6,907.9% during the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 749,703 shares of the company’s stock valued at $75,593,000 after purchasing an additional 739,005 shares in the last quarter. Worldquant Millennium Advisors LLC acquired a new position in Clorox during the second quarter valued at approximately $71,856,000. Finally, Two Sigma Investments LP lifted its stake in Clorox by 33.8% during the third quarter. Two Sigma Investments LP now owns 1,740,175 shares of the company’s stock worth $214,564,000 after purchasing an additional 439,797 shares during the last quarter. 78.53% of the stock is owned by institutional investors.

Clorox Stock Performance

Shares of Clorox stock opened at $95.66 on Friday. The Clorox Company has a fifty-two week low of $84.70 and a fifty-two week high of $128.90. The company has a debt-to-equity ratio of 27.03, a current ratio of 0.84 and a quick ratio of 0.65. The firm has a market capitalization of $11.57 billion, a P/E ratio of 15.53 and a beta of 0.54. The company’s 50 day moving average price is $95.51 and its two-hundred day moving average price is $103.67.

Clorox (NYSE:CLX) last posted its earnings results on Thursday, April 30th. The company reported $1.64 earnings per share for the quarter, topping analysts’ consensus estimates of $1.55 by $0.09. The firm had revenue of $1.67 billion for the quarter, compared to analysts’ expectations of $1.67 billion. Clorox had a net margin of 11.18% and a return on equity of 443.64%. The company’s revenue was up .1% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.45 earnings per share. On average, equities analysts forecast that The Clorox Company will post 5.52 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of brokerages have weighed in on CLX. Barclays raised their target price on Clorox from $85.00 to $86.00 and gave the company an “underweight” rating in a report on Tuesday, July 21st. Weiss Ratings reissued a “hold (c-)” rating on shares of Clorox in a report on Friday, July 10th. Zacks Research downgraded Clorox from a “hold” rating to a “strong sell” rating in a research report on Tuesday, May 12th. JPMorgan Chase & Co. reduced their price objective on Clorox from $95.00 to $92.00 and set an “underweight” rating on the stock in a research note on Thursday, July 16th. Finally, Jefferies Financial Group cut Clorox from a “buy” rating to a “hold” rating and decreased their target price for the company from $125.00 to $98.00 in a research report on Tuesday. Twelve analysts have rated the stock with a Hold rating and five have issued a Sell rating to the company’s stock. According to data from MarketBeat.com, Clorox has an average rating of “Reduce” and a consensus target price of $101.00.

Insider Buying and Selling at Clorox

In other news, Director Pierre R. Breber acquired 5,000 shares of the business’s stock in a transaction that occurred on Tuesday, May 5th. The shares were bought at an average price of $85.82 per share, with a total value of $429,100.00. Following the acquisition, the director directly owned 18,000 shares in the company, valued at $1,544,760. The trade was a 38.46% increase in their position. The acquisition was disclosed in a filing with the SEC, which is available through this hyperlink. 0.63% of the stock is currently owned by company insiders.

Clorox Profile

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.